Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Proteomics & DIA Mass Spectrometry in Neurodegenerative Disease Research

News-Medical Life Sciences spoke to Nicholas Dupuis from Biognosys about proteomics & DIA mass spectrometry in neurodegenerative disease research.

From Biognosys 19 Nov 2019

Potential new therapy for progeria

Aging is a complex and natural process that affects all living organisms. As people age, normal biological processes are affecting, resulting in a decline in various organs and age-related conditions. Though aging is normal, some children affected by a disease called Progeria may age way faster than others.

18 Nov 2019

UCLA Health pulmonologist describes the signs and symptoms of lung cancer

Nikki Moreno, a 42-year-old mother of two, was not expecting to hear she had advanced lung cancer when she ended up in the emergency room at the UCLA Medical Center, Santa Monica, last October. She hadn't been feeling well for over a year but didn't think too much of her symptoms.

15 Nov 2019

PhoreMost and Sentinel Oncology expand partnership to advance novel allosteric PLK1 inhibitor

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, and Sentinel Oncology, today announce an expansion of their collaboration to accelerate the progression of SOL686, a novel allosteric Polo-like kinase 1 (PLK1) inhibitor through preclinical development and IND enabling studies for the treatment of Glioma.

From PhoreMost 15 Nov 2019

Research explains why immunotherapy fails against prostate cancer bone metastases

Prostate cancer that spreads to the bone triggers the destruction of bone tissue that, in turn, thwarts the effectiveness of immune checkpoint inhibitors by blocking the development of T cells that are crucial to successful treatment, researchers from The University of Texas MD Anderson Cancer Center report in Cell.

14 Nov 2019

Integral Molecular receives NIH contract for $5.5 million to advance vaccine discovery

The National Institute of Allergy and Infectious Diseases has awarded Integral Molecular a contract (75N93019C00073) which will provide up to $5.5M over the next five years to define antibody responses to pathogenic viruses including Zika, Marburg and equine encephalitis viruses, aiding the discovery of vaccines and therapeutics against these currently untreatable and often lethal viruses.

14 Nov 2019

FDA grants acceptance to application for selumetinib as treatment for neurofibromatosis

AstraZeneca and MSD (Merck) announced today that the U.S. Food and Drug Administration (FDA) has granted acceptance to file status of its application for the MEK inhibitor selumetinib, for use in patients with plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1).

14 Nov 2019

Turbine secures institutional financing of €3m to expand potential of simulation-first drug discovery

Turbine, a simulation-based drug discovery company today announced the closing of an institutional financing round led by Delin Ventures.

From Turbine Simulated Cell Technologies Ltd. 14 Nov 2019

Secondary surgery for recurrent ovarian cancer patients does not result in longer survival

Researchers from The University of Texas MD Anderson Cancer Center reported that secondary tumor-reduction, or cytoreduction, surgery followed by chemotherapy did not result in longer survival than chemotherapy alone in patients with platinum-sensitive recurrent ovarian cancer.

13 Nov 2019

Pacemaker-like device improves heart function in patients with chemotherapy-induced cardiomyopathy

With the advent of new therapies, cancer patients are surviving longer than ever before -- but the incidence of side-effect chemotherapy-induced cardiomyopathy (CHIC), or weakness of the heart muscle, is increasing.

13 Nov 2019

Clinical analysis reveals high expression of apoptosis protein in chemoresistant TNBC

78 TNBC biopsies from patients with different responses to chemotherapy were analysed for API-5 expression before any treatment.

13 Nov 2019

New IASLC policy statement discourages the use of e-cigarettes by non-smokers

The IASLC is the world's largest multidisciplinary lung cancer organization and the new policy statement coincides with Lung Cancer Awareness Month.

13 Nov 2019

Johns Hopkins launches new center for 'immunoengineering' research

If the saying that two heads are better than one is true, then joining two fields of science may be better than one to spur more advances in medicine.

13 Nov 2019

Novartis announces strategy to broaden patient reach and availability of medicines in sub-Saharan Africa

Novartis announced today a new strategy to broaden patient reach and availability of its portfolio of medicines in sub-Saharan Africa, which is home to the largest underserved patient population in the world.

13 Nov 2019

Cardiac resynchronization therapy improves heart function in cancer survivors

A pacemaker-like device restored heart function in a group of cancer survivors -- mostly women with breast cancer -- who had suffered from heart failure as a result of chemotherapy treatment, a study in the Journal of the American Medical Association reports.

12 Nov 2019

Women from ethnic minority backgrounds face barriers to seeking medical attention

England is a multi-ethnic society, often characterized as a “super-diversity” country. The ethnic minority background as doubled in size from 2001 to 2011 and the number steadily increases. Super-diversity pertains to a shift in recent immigration patterns, which allows other ethnicities from across the globe, to move and live in the region.

12 Nov 2019

Popular cancer drug linked to weight gain and increased systolic blood pressure

Women from ethnic minority backgrounds face more barriers to seeking medical help

The study published in Psycho-Oncology found that, in England, women from ethnic minority backgrounds were more likely to feel too embarrassed to talk to a GP (75-91%) than white women (8%).

11 Nov 2019

Rutgers researcher receives $600,000 grant to study chronic lymphocytic leukemia

Rutgers Cancer Institute of New Jersey researcher Hossein Khiabanian, PhD, has received a $600,000 Translational Award from the V Foundation for Cancer Research to study chronic lymphocytic leukemia with the aim of developing research models that may help investigators better understand how CLL cells are influenced by new therapies.

11 Nov 2019

Mirada Medical announces series of installations of world’s first AI software for cancer treatment

Mirada Medical, a global leader in Artificial Intelligence software for the treatment of cancer, has announced today further global installations of DLCExpert, the world’s first commercially available AI-powered auto contouring software for cancer treatment planning and the only system with over one year of clinically proven use.

11 Nov 2019

Oncology News and Research

Further Reading

Proteomics & DIA Mass Spectrometry in Neurodegenerative Disease Research

Potential new therapy for progeria

UCLA Health pulmonologist describes the signs and symptoms of lung cancer

PhoreMost and Sentinel Oncology expand partnership to advance novel allosteric PLK1 inhibitor

Research explains why immunotherapy fails against prostate cancer bone metastases

Integral Molecular receives NIH contract for $5.5 million to advance vaccine discovery

FDA grants acceptance to application for selumetinib as treatment for neurofibromatosis

Turbine secures institutional financing of €3m to expand potential of simulation-first drug discovery

Secondary surgery for recurrent ovarian cancer patients does not result in longer survival

Pacemaker-like device improves heart function in patients with chemotherapy-induced cardiomyopathy

Clinical analysis reveals high expression of apoptosis protein in chemoresistant TNBC

New IASLC policy statement discourages the use of e-cigarettes by non-smokers

Johns Hopkins launches new center for 'immunoengineering' research

Novartis announces strategy to broaden patient reach and availability of medicines in sub-Saharan Africa

Cardiac resynchronization therapy improves heart function in cancer survivors

Women from ethnic minority backgrounds face barriers to seeking medical attention

Popular cancer drug linked to weight gain and increased systolic blood pressure

Women from ethnic minority backgrounds face more barriers to seeking medical help

Rutgers researcher receives $600,000 grant to study chronic lymphocytic leukemia

Mirada Medical announces series of installations of world’s first AI software for cancer treatment

Event guide: 10th CAR-TCR Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News